The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4338-4344

  Carruth, L M ^a   Morse, B A ^a   Clements, J E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; LEUCINE; MUTANT PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SHEEP; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION; VISNA VIRUS;

EID: 0029949794     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4338-4344.1996     Document Type: Article

References (44)

1. Abate, C., D. Luk, and T. Curran. 1991. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains. Mol. Cell. Biol. 11:3624-3632.
2. Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature (London) 332:166-171.
3. Beraud, C., G. Lombard-Platet, Y. Michal, and P. Jalinot. 1991. Binding of the HTLV-1 Taxi transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1. EMBO J. 10:3795-3803.
4. Berkhout, B., R. H. Silverman, and K. T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
5. Carruth, L. M., S. L. Gdovin, and J. E. Clements. Unpublished data.
6. Carruth, L. M., J. M. Hardwick, B. A. Morse, and J. E. Clements. 1994. Visna virus Tat protein: a potent transcription factor with both activator and repressor domains. J. Virol. 68:6137-6146.
7. Choy, B., and M. R. Green. 1993. Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature (London) 366:531-536.
8. Connor, L. M., M. N. Oxman, J. N. Brady, and S. J. Marriott. 1993. Twenty-one base pair repeat elements influence the ability of Ga14-Tax fusion protein to transactivate the HTLV-1 long terminal repeat. Virology 195:569-577.
9. Davis, J. L., and J. E. Clements. 1988. Characterization of a cDNA clone encoding the visna virus trans-activating protein. Proc. Natl. Acad. Sci. USA 86:414-418.
10. Derse, D., M. Carvalho, R. Carroll, and B. M. Peterlin. 1991. A minimal lentivirus Tat. J. Virol. 65:7012-7015.
11. Dingwall, C., J. Ernberg, M. Gait, S. Green, S. Heaphy, J. Karn, A. Lowe, M. Singh, M. Skinner, and R. Valerio. 1989. Human immunodeficiency virus 1 tat protein binds trans-activation-response region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86:6925-6929.
12. Frankel, A. D., D. S. Bredt, and C. O. Pabo. 1988. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240:70-73.
13. Gabuzda, D. H., J. L. Hess, J. A. Small, and J. E. Clements. 1989. Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol. Cell. Biol. 9:2728-2733.
14. Gdovin, S. L., and J. E. Clements. 1992. Molecular mechanisms of visna virus tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology 188:438-450.
15. Gendelman, H. E., T. R. Moench, O. Narayan, D. E. Griffin, and J. E. Clements. 1985. A double labelling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J. Virol. Methods 11:93-103.
16. Gendelman, H. E., O. Narayan, S. Molineaux, J. E. Clements, and Z. Ghotbi. 1985. Slow persistent replication of lentiviruses: role of tissue macrophages and macrophage-precursors in bone marrow. Proc. Natl. Acad. Sci. USA 82:7086-7090.
17. Hardwick, J. M., L. Tse, N. Applegren, J. Nicholas, and M. A. Veliuona. 1992. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J. Virol. 66:5500-5508.
18. Hess, J. L., J. A. Small, and J. E. Clements. 1989. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activatiun: involvement of AP-1 sites in basal activity and transactivation. J. Virol. 63:3001-3015.
19. Hsu, W., T. K. Kerppola, P. L. Chen, T. Curran, and S. Chen-Kiang. 1994. Fos and Jun repress transcription activation by NF-1L6 through association at the basic zipper region. Mol. Cell. Biol. 14:268-276.
20. Kamine, J., T. Subramanian, and G. Chinnadurai. 1991. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 88:8510-8514.
21. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fallacy, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature (London) 367:295-299.
22. Kerppola, T. K., D. Luk, and T. Curran. 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:3782-3791.
23. Li, Y., G. Mak, and B. R. Franza. 1994. In vitro study of functional involvement of Sp1, NF-kappa B/Re1 and AP1 in phorbol 12-myristate 13-acetate-mediate HIV-1 long terminal repeat activation. J. Biol. Chem. 269:30616-30619.
24. Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature (London) 338:39-44.
25. Luo, Y., and B. M. Peterlin. 1993. Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. J. Virol. 67:3441-3445.
26. Mohamed, M. K., L. Tung, G. S. Takimoto, and K. B. Horwitz. 1994. The leucine zippers of c-Fos and c-Jun for progesterone receptor dimerization - a dominance in the A/B heterodimer. J. Steroid Biochem. Mol. Biol. 51:241-250.
27. Morse, B. A., L. M. Carruth, and J. E. Clements. Unpublished data.
28. Narayan, O., and L. C. Cork. 1985. Lentiviral diseases of sheep and goats. Chronic pneumonia, leukoencephalomyelitis and arthritis. Rev. Infect. Dis. 7:89-98.
29. Neuveut, C., R. Vigne, J. E. Clements, and J. Sire. 1993. The visna transcriptional activator TAT: effects on the viral LTR and on cellular genes. Virology 197:236-244.
30. Norcross, M. A., G. Roderiquez, M. Bagnato, and L. Callahan. 1988. Characterization of HIV-1 enhancer function and enhancer-binding proteins, p. 203-215. In B. R. Franza, B. R. Cullen, and F. Wong-Staal (ed.), Control of human retrovirus gene expression. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
31. Ptashne, M. 1988. How eukaryotic transcriptional activators work. Nature (London) 335:683-689.
32. Ptashne, M., and A. A. F. Gann. 1990. Activators and targets. Nature (London) 346:329-331.
33. Shin, D. S., L. M. Carruth, M. Anderson, and J. E. Clements. 1992. Involvement of FOS and JUN in the activation of visna virus gene expression in macrophages through an AP-1 site in the viral LTR. Virology 190:84-91.
34. Small, J. A., C. Bieberich, Z. Ghotbi, J. Hess, G. A. Scangos, and J. E. Clements. 1989. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J. Virol. 63:1891-1896.
35. Sollerbrant, K., G. Akusjarvi, S. Linder, and C. Svensson. 1995. The DNA binding domains of the yeast Ga14 and human c-Jun transcription factors interact through the zinc-finger and bZIP motifs. Nucleic Acids Res. 23:588-594.
36. Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5:2496-2507.
37. Stringer, K. F., C. J. Ingles, and J. Greenblatt. 1990 Direct and selective binding of an acidic transcriptional activation domain to the TATA box factor TFIID. Nature (London) 345:783-786.
38. Suckow, M., K. Schwamborn, B. Kisters-Woike, B. von Wilcken-Bergmann, and B. Muller-Hill. 1994. Replacement of invariant bZIP residues within the basic region of the yeast transcriptional activator GCN4 can change its DNA binding specificity. Nucleic Acids Res. 22:4395-4404.
39. Tanimura, A., H. Teshima, J.-I. Fujisavta, and M. Yoshida. 1993. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins. J. Virol. 67:5375-5382.
40. Tiley, L. S., P. H. Brown, S. Y. Le, J. V. Maizel, J. E. Clements, and B. R. Cullen. 1990. Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc. Natl. Acad. Sci. USA 87:7497-7501.
41. Vinson, C. R., T. Hai, and S. M. Boyd. 1993. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes Dev. 7:1047-1058.
42. Walker, S., S. Haves, and P. O'Hare. 1994. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16). Cell 79:841-852.
43. Xanthoudakis, S., and T. Curran. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 11:653-665.
44. Xanthoudakis, S., G. G. Miao, and T. Curran. 1994. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. USA 91:23-27.